Filed: 1/29/2025ACC: 0001999371-25-000847
📋 What this filing means
WILDCAT CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $252.71M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$252.71M
Total AUM (reported)
50.95M
Total Shares
Allocation by class
COM$212.86M84.2%
SPONSORED ADS$38.98M15.4%
CLASS A COM$642.3K0.3%
SHS NEW$228.0K0.1%
Portfolio Concentration
Top 3$244.72M96.8%
4–10$7.99M3.2%
Top 3 weight
96.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 50.95M
Sole
Full voting authority
50.95M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings8
Rows:
FRONTIER GROUP HLDGS INC
SOLEShares28.06M
TypeSH
Market value$199.52M
78.95%
Sole
28.06M
Shared
0.00
None
0.00
RLX TECHNOLOGY INC
SOLEShares18.05M
TypeSH
Market value$38.98M
15.42%
Sole
18.05M
Shared
0.00
None
0.00
ALLOGENE THERAPEUTICS INC
SOLEShares2.92M
TypeSH
Market value$6.22M
2.46%
Sole
2.92M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares495.61K
TypeSH
Market value$5.28M
2.09%
Sole
495.61K
Shared
0.00
None
0.00
KRONOS BIO INC
SOLEShares1.30M
TypeSH
Market value$1.23M
0.49%
Sole
1.30M
Shared
0.00
None
0.00
GITLAB INC
SOLEShares11.40K
TypeSH
Market value$642.3K
0.25%
Sole
11.40K
Shared
0.00
None
0.00
PROCORE TECHNOLOGIES INC
SOLEShares8.10K
TypeSH
Market value$606.6K
0.24%
Sole
8.10K
Shared
0.00
None
0.00
SILEXION THERAPEUTICS CORP
SOLEShares113.43K
TypeSH
Market value$228.0K
0.09%
Sole
113.43K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
FRONTIER GROUP HLDGS INCSOLE | COM | 28.06M | SH | $199.52M 78.95% | 28.06M | 0.00 | 0.00 |
RLX TECHNOLOGY INCSOLE | SPONSORED ADS | 18.05M | SH | $38.98M 15.42% | 18.05M | 0.00 | 0.00 |
ALLOGENE THERAPEUTICS INCSOLE | COM | 2.92M | SH | $6.22M 2.46% | 2.92M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 495.61K | SH | $5.28M 2.09% | 495.61K | 0.00 | 0.00 |
KRONOS BIO INCSOLE | COM | 1.30M | SH | $1.23M 0.49% | 1.30M | 0.00 | 0.00 |
GITLAB INCSOLE | CLASS A COM | 11.40K | SH | $642.3K 0.25% | 11.40K | 0.00 | 0.00 |
PROCORE TECHNOLOGIES INCSOLE | COM | 8.10K | SH | $606.6K 0.24% | 8.10K | 0.00 | 0.00 |
SILEXION THERAPEUTICS CORPSOLE | SHS NEW | 113.43K | SH | $228.0K 0.09% | 113.43K | 0.00 | 0.00 |